16 |
NIRS-IVUS: Imaging to Guide Optimal PCI |
James A. Goldstein |
Apr. 21. 16 |
15 |
[Interesting Image Case Reviews] NIRS |
Junho Lim |
Dec. 08. 15 |
14 |
Vulnerable Plaque Detection by Grayscale IVUS and NIRS |
Akiko Maehara |
Dec. 08. 15 |
13 |
NIR Imaging in the Cath Lab: When & How |
Joon-Won Kang |
Apr. 21. 15 |
12 |
Will Combined IVUS-NIRS Imaging Improve Our Ability to Predict Culprit Lesions? |
James E. Muller |
Apr. 21. 15 |
11 |
How to Assess Biological Activity of Inflammarory Plaque?: Combined OFDI-NIRF Molecular Imaging |
Jin Won Kim |
Apr. 21. 15 |
10 |
Clinical Trials by Using NIRS: Clinical Relevance and Prognostic Implication |
Akiko Maehara |
Apr. 21. 15 |
9 |
NIR: PROSPECT II and PROSPECT ABSORB Trial |
Akiko Maehara |
Dec. 09. 14 |
8 |
NIRS-IVUS to Predict Long Term Outcome |
Akiko Maehara |
Dec. 09. 14 |
7 |
NIRS vs. IVUS: Lessons from in Vivo ACS Patients and in Vitro SCD Cases |
Jun Pu |
Dec. 09. 14 |